SpyGlass Pharma, Inc. Common Stock

NASDAQ:SGP

Biotechnology

Healthcare
$29.68 +2.49%

+$0.45 today

Market cap
$993.14M
Beta
-0.34
P/E (TTM)
-14.1
EPS (TTM)
-$1.32
52W Low $17.06High $32.44

Volume 0.10M

Average 0.09M

SGP Investing Cash Flow

Net cash used in or generated by investments in assets, acquisitions, and securities.

SpyGlass Pharma, Inc. Common StockNASDAQ: SGP

Investing Cash Flow · Q1 FY2026 · quarter ended Mar 2026

Investing cash flow of -$1.67M in Q1 FY2026

Q1 FY2026 investing cash flow was -$1.67M.

Sources:Cash FlowText generated from reported figures; not investment advice.

Latest quarterMar 2026
-$1.67M-390.1% QoQ
Last fiscal yearDec 2025
-$11.79M— YoY
Investing Cash Flow past and forecast growth by horizon
Horizon Past Forecast Difference
Quarter———
1 year———
3-year CAGR———
5-year CAGR——
10-year CAGR——

Investing Cash Flow history

USD · from the cash flow

Latest · FY2025
(11.79M) USD
Year-over-year change
—

Investing Cash Flow vs competitors

How SGP compares with its peers on the latest reported figures

  • Peers report in different currencies, so investing cash flow is compared through growth and share of revenue rather than absolute size.
SGP Competitors
Investing Cash Flow for SGP and competitors
Company Period LTM YoY 3-year CAGR% of revenue
ALCAlcon Inc.LTM Sep 2026$928.77M USD-32.1%-10.3%8.5%
BLCOBausch + Lomb CorporationLTM Jun 2026$463.16M USD-4.9%+28.4%8.7%
EYPTEyePoint Pharmaceuticals, Inc.LTM Mar 2026$88.11M USD+143.9%—1157.0%
OCSOculis Holding AGLTM Mar 2026CHF 35.56M CHF-46.9%+155.8%7055.6%
GKOSGlaukos CorporationLTM Jun 2026$14.69M USD-4.5%—2.4%
OCULOcular Therapeutix, Inc.LTM Mar 2026$14.61M USD+392.5%+47.3%28.1%
STAASTAAR Surgical CompanyLTM Apr 2026$13.14M USD+132.8%—4.5%
SGPSpyGlass Pharma, Inc. Common StockFY2025$11.79M USD———
RXSTRxSight, Inc.LTM Mar 2026$4.88M USD+104.8%-24.9%3.8%
SGHTSight Sciences, Inc.LTM Mar 2026$284K USD+6.0%-38.6%0.4%
Peer median (excluding SGP) —+6.0%+9.0%8.5%

Competitors are the stored peer set for SGP. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

SpyGlass Pharma, Inc. Common Stock

NASDAQ:SGP

Intrinsic Alpha fair value

Locked

Current Price

$29.68

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.